Repotrectinib
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Repotrectinib, covering 2024-04-02 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC [Phase 2]